Company
United StatesPublic company, NYSE: EBSEmergent Biosolutions LLC (NYSE: EBS), Canton, MA – FDA Inspections
Inspection records and compliance data for Emergent Biosolutions LLC in Canton, Massachusetts. 6 FDA inspections on record, 2 Form 483s, last inspected February 10, 2026. Publicly traded as NYSE: EBS.
Company Profile
This profile covers Emergent Biosolutions LLC based in Canton, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 5
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected October 15, 2008. Last inspected February 10, 2026.
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 10, 2026 | Not classified | Biologics | 1309368 |
| August 16, 2023 | VAI | Biologics · Vaccines and Allergenic Products | 1215398 |
| December 21, 2017 | VAI | Biologics · Vaccines and Allergenic Products | 1041003 |
| May 2, 2013 | VAI | Biologics · Vaccines and Allergenic Products | 830320 |
| September 22, 2010 | VAI | Biologics · Vaccines and Allergenic Products | 684124 |
| October 15, 2008 | VAI | Biologics · Vaccines and Allergenic Products | 544784 |
FDA documents
EIRs (1)
People (6)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Sarepta Therapeutics Inc
Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb
GlaxoSmithKline Vaccines S.r.l.
Haematologic Technologies, LLC dba Prolytix
North American Science Associates, LLC
Nelson Laboratories, LLC
2seventy Bio, Inc.
University of Massachusetts Incorporated
Diagnostic Services of Kansas State, Inc.
Valneva Austria GmbH
Company Information
Name
Emergent Biosolutions LLC
Stock ticker
EBS
Exchange
NYSE
Share price
$5.88
Market cap
$302.3M
Price as of
November 13, 2026
FEI Number
3004051669
Address
50/90 Shawmut Rd, Canton, Massachusetts 02021, United States
Country
United States
ID: a4e71e63-5d44-4dd7-a589-a755c72b0637